[Heart-specific L-myosin in pregnancy and tocolysis therapy].
Determination of light-chain (L-)myosin represents the currently most sensitive and specific method for detection of myocardial damage, which often was reported during tocolysis with betamimetics. Compared with 51 healthy pregnant subjects, it was not possible to demonstrate any pathologic increase in 14 patients, who underwent a tocolytic treatment with ritodrine-verapamil.
Lechner
W
W
Univ.-Klinik für Frauenheilkunde Innsbruck.
Artner-Dworzak
E
E
Heim
K
K
Marth
C
C
Puschendorf
B
B
D000328:Adult; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood* / Q000139:chemically induced; D005260:Female; D006801:Humans; D009218:Myosins / Q000097:blood*; D007744:Obstetric Labor Complications / Q000097:blood / Q000188:drug therapy*; D011247:Pregnancy / Q000097:blood*; D012312:Ritodrine / Q000009:adverse effects; D015149:Tocolytic Agents / Q000009:adverse effects*; D014700:Verapamil / Q000009:adverse effects
D015415:Biomarkers; D015149:Tocolytic Agents; D014700:Verapamil; D009218:Myosins; D012312:Ritodrine
Herzspezifisches L-Myosin bei Schwangerschaft und Tokolysetherapie.